期刊文献+

血清降钙素原指导成人下呼吸道感染抗菌治疗73例 被引量:7

Serum Procalcitonin-guided Antibiotic Therapy of 73 Cases with Adult Lower Respiratory Tract Infection
下载PDF
导出
摘要 目的利用血清降钙素原(PCT)水平指导抗菌药物使用,减少下呼吸道感染患者抗菌药物暴露,降低医疗费用。方法收集2015—2017年成人下呼吸道感染患者131例,随机分为试验组(73例)和对照组(58例)。对照组参照相关指南进行抗感染治疗,试验组同时参考PCT水平;以患者死亡、转入重症监护室(ICU)、发生并发症及30d内复发感染需要抗菌药物治疗为研究终点,比较两组患者抗菌药物疗程、金额及住院费用的差异性。结果两组患者死亡、转入ICU、发生并发症以及30d内复发感染需要抗菌药物治疗等指标均差异无统计学意义(P>0.05);试验组临床有效率为93.2%,较对照组高。试验组和对照组抗菌药物疗程分别为(6.14±2.19),(8.16±2.95)d,两组比较差异有统计学意义(P<0.05);试验组与对照组抗菌药物金额分别为(1219.92±868.80),(1977.82±1042.18)元,住院费用分别为(5621.57±1335.09),(7415.05±1553.47)元,两组比较均差异有统计学意义(P<0.05)。结论血清PCT水平指导成人下呼吸道感染抗菌治疗可在不增加安全风险的情况下减少抗菌药物暴露,降低住院费用,具有一定的临床价值。 Objective Use serum procalcitonin(PCT)levels to guide the use of antibiotics to reduce exposure time and reduce medical costs in patients with lower respiratory tract infections.Methods Collecting 131 cases of adult lower respiratory tract infection patients from 2015 to 2017.Patients were randomly divided into experimental group(73 cases)and control group(58 cases).The control group was treated with anti-infective treatment according to the relevant guidelines.The use of antibiotics in experimental group according to the PCT level.The study ended with patient death,transfer to ICU,complications,and recurrent infection within 30 days.The differences in the course and amount of antibacterial drugs and hospitalization costs between the two groups were compared.Results There were no significant differences between the two groups in terms of death,transfer to the ICU,complications,and relapse infection within 30 days(P<0.05).The clinical effective rate of the experimental group was 93.2%,which was higher than that of the control group.The course of antibiotics in the experimental group and the control group were(6.14±2.19)d and(8.16±2.95)d,respectively.The difference between the two groups was statistically significant(P<0.05).The amount of antibiotics in the experimental group and the control group were(1 219.92±868.80)yuan and(1 977.82±1 042.18)yuan,respectively;the hospitalization expenses were(5 621.57±1 335.09)yuan and(7 415.05±1 553.47)yuan,respectively.The difference between the two groups was statistically significant(P<0.05).Conclusion Serum PCT level can guide adult anti-infection of lower respiratory tract infection,which can reduce the exposure of antibiotics and reduce the cost of hospitalization without increasing the safety risk.It has certain clinical value.
作者 张学会 李娜 金泰宇 谢林艳 吴静 赵萍 ZHANG Xuehui;LI Na;JIN Taiyu;XIE Linyan;WU Jing;ZHAO Ping(Department of Pharmacology,the Affiliated Jiangsu Shengze Hospital of Nanjing Medical University ,Suzhou 215228,China;Department of Pharmacology,Xinxiang Central Hospital,Henan Province,Xinxiang 453002,China;Department of Pharmacy,the Second People' s Hospital of Lianyungang,Jiangsu Province,Lianyungang 222000,China;Department of Respiratory Medicine,the Affiliated Jiangsu Shengze Hospital of Nanjing Medical University,Suzhou 215228 ,China;Department of Clinical Laboratory,Jiangsu Shengze Hospital,Suzhou 215228,China)
出处 《医药导报》 CAS 北大核心 2019年第8期1026-1029,共4页 Herald of Medicine
基金 2016年江苏省科教强卫工程青年医学人才项目(QNRC2016215) 2015年苏州市科技发展计划(应用基础研究-卫生医疗)项目(SYSD2015047,SYSD2015148)
关键词 降钙素原 下呼吸道感染 抗菌药物 Procalcitonin Lower respiratory tract infection Antibiotic agents
  • 相关文献

参考文献2

二级参考文献31

  • 1田丁,苏力,冀冰心,赵弘.美罗培南在血液系统疾病合并感染时的应用[J].中国抗生素杂志,2004,29(8):462-464. 被引量:12
  • 2周凡,刘丽梅,刘彦琴,郭步云,朴英,刘景华.血清降钙素原在恶性血液病感染中的变化及临床意义[J].沈阳部队医药,2005,18(3):202-203. 被引量:3
  • 3常春,姚婉贞,陈亚红,刘振英,张晓伟.慢性阻塞性肺疾病患者急性加重期血清降钙素原水平的变化及临床意义[J].中华结核和呼吸杂志,2006,29(7):444-447. 被引量:93
  • 4卫生部,国家中医药管理局,总后卫生部.抗菌药物临床应用指导原则[S].卫医发[2004]285号,2004:11.
  • 5STAMER U M, BOOK M, COMOS C, et al. Expression of the nociceptin precursor and nociceptin receptor is modulated in cancer and septic patients [ J ]. Br J Anaesth, 2011,106 (4) :566-572.
  • 6BRIEL M, SCHUETZ P, MUELLER B, et al. Procalcitonin- guided antibioticuse vs a standard approach for acute respiratory tract infections inprimary care [ )]. Arch lnt Med,2008,168 (10) : 2000-2007.
  • 7MATSUMOTO T, MURATANI T. Newer carbapenems for urinary tract infections [ J ]. Int J Antimicrob Agents, 2004, 24(1) :35-38.
  • 8SCHUTTRUM F S, BINDER L, HAGEMANN T, et al. Procalcltonln: a useful discrim inator between febrile conditions of different originin hemato-oncological patients [J]. Ann nematol,2003,82(2) :98-103.
  • 9GIAMARELLOS-BOURBOULIS E J, GRECKA P, POULA- KOU G,et al. Assessment of procalciton in as a diagnostic marker of underying infection in patients with febrile neutropenia[ J ]. Clin Infect Dis, 2001,32 (12) : 1718 - 1725.
  • 10MARUNA P, NEDELNIKOVA K, GURLICH R. Physiology and geneticsof procalcitonin [ J ]. Physiol Res, 2000, 49 (Suppl 1 ) :57-61.

共引文献45

同被引文献49

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部